FDA Approves Antiviral Remdesivir As COVID-19 Treatment

Eurasia Review

Published

The US Food and Drug Administration (FDA) has approved Gilead Sciences’ expensive antiviral drug remdesivir to treat Covid-19, expanding its earlier emergency use authorization and guaranteeing huge profits for the company.

Remdesivir has become the first and only drug to be officially approved in the US for treating...

Full Article